Genetic Signatures is a proud sponsor of the Klinisch-Mikrobiologisch-Infektiologische Symposium (KMIS), held in Berlin from the 2nd to 5th of December 2021.
This years’ symposium addresses the range of effort across all health and medical disciplines to diagnose, manage, treat, and vaccinate against SARS-CoV-2. Genetic Signatures has played a key role in supporting the rapid real-time PCR testing of SARS-CoV-2 variants, and other key respiratory pathogens, using our unique molecular 3base™ technology. Learn more about our syndromic solutions here. Full details and the program http://www.kmis.de/
Contact us to speak to your local representative to learn more about Genetic Signatures’ molecular syndromic testing solutions.